NarxCare drug addition risk assessment
Released: TBC
Can you improve this page?
Share your insights with us
WIRED reports that NarxCare, a software system that uses patient data, drug use data, and metadata to determine the risk of drug addiction is denying users opioids on the basis it thinks they are at risk of addiction.
Patients complain that the system, developed by Appriss, can be inaccurate and unfair. It is believed to reinforce existing racial and gender biases.
Appriss has failed to disclose how the NarxCare system works, and does not provide access to its data, model or code. The company has also made a number of contradictory claims about the algorithm's data sources and other inputs.
Operator: US Department of Justice; Rite Aid; Walmart; Sam's Club
Developer: Appriss
Country: USA
Sector: Healthcare/pharma
Purpose: Assess & predict drug abuse
Technology: Risk assessment algorithm
Issue: Fairness; Accuracy/reliability
Transparency: Governance; Black box; Marketing
System
Research, advocacy
https://www.annemergmed.com/article/S0196-0644(22)00243-8/fulltext
https://www.sciencedirect.com/science/article/abs/pii/S0376871621005627?via%3Dihub
News, commentary, analysis
https://www.wired.com/story/opioid-drug-addiction-algorithm-chronic-pain/
https://www.thedoctorpatientforum.com/resources/faqs/290-what-is-narxcare
https://www.painnewsnetwork.org/stories/2021/8/31/the-tangled-mess-of-prescription-opioid-guidelines
https://www.reddit.com/r/medicine/comments/p2ofkc/a_sweeping_drug_addiction_risk_algorithm_has/
Page info
Type: System
Published: September 2021